Mono Pharmacare Limited (NSE: MONOPHARMA)

Market Cap	636.07M
Revenue (ttm)	1.43B
Net Income (ttm)	28.70M
Shares Out	17.67M
EPS (ttm)	1.62
PE Ratio	22.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	28.10 - 75.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Mono Pharmacare

Mono Pharmacare Limited engages in the marketing and distribution of pharmaceutical products in India. The company offers products in various categories, such as antibiotics, anti-fungal, anti cough- cold and anti-allergic, antacid and antiemetics, analgesic and antipyretic, nutraceuticals, skin care, antiseptic, cardiac and diabetics, cosmetics, etc. It also sells its pharmaceutical products under the DLS Export brand name. The company was founded in 1994 and is based in Ahmedabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In 2023, Mono Pharmacare's revenue was 1.22 billion, an increase of 269.41% compared to the previous year's 331.44 million. Earnings were 24.42 million, an increase of 158.84%.